KCM
PMD

Kennedy Capital Management’s Psychemedics Corporation PMD Stock Holding History

Kennedy Capital Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-177,241
Closed -$782K – 711
2020
Q3 		$782K Sell
177,241
-238,238
-57% -$1.16M 0.02% 569
2020
Q2 		$2.31M Sell
415,479
-66,258
-14% -$370K 0.07% 474
2020
Q1 		$2.92M Buy
481,737
+103,905
+28% +$875K 0.11% 354
2019
Q4 		$3.46M Buy
377,832
+1,718
+0.5% +$15.9K 0.08% 436
2019
Q3 		$3.43M Sell
376,114
-49,991
-12% -$425K 0.09% 430
2019
Q2 		$4.3M Buy
426,105
+203,068
+91% +$2.3M 0.1% 366
2019
Q1 		$3.13M Buy
223,037
+79,263
+55% +$1.36M 0.07% 464
2018
Q4 		$2.28M Buy
143,774
+80,328
+127% +$1.38M 0.06% 514
2018
Q3 		$1.19M Sell
63,446
-4,225
-6% -$84.1K 0.02% 626
2018
Q2 		$1.3M Buy
67,671
+12,402
+22% +$251K 0.02% 644
2018
Q1 		$1.18M Buy
+55,269
New +$1.15M 0.02% 653
2016
Q4 		– Sell
-74,226
Closed -$1.47M – 772
2016
Q3 		$1.47M Sell
74,226
-94,597
-56% -$1.75M 0.03% 620
2016
Q2 		$2.32M Sell
168,823
-9,653
-5% -$134K 0.05% 542
2016
Q1 		$2.45M Sell
178,476
-71,000
-28% -$814K 0.05% 548
2015
Q4 		$2.53M Buy
249,476
+7,816
+3% +$85.1K 0.05% 534
2015
Q3 		$2.43M Sell
241,660
-26,484
-10% -$309K 0.05% 533
2015
Q2 		$3.98M Sell
268,144
-24,803
-8% -$386K 0.07% 453
2015
Q1 		$4.86M Buy
292,947
+1,484
+0.5% +$23.2K 0.09% 411
2014
Q4 		$4.42M Sell
291,463
-4,877
-2% -$70.8K 0.08% 429
2014
Q3 		$4.2M Buy
296,340
+7,708
+3% +$110K 0.08% 411
2014
Q2 		$4.09M Buy
288,632
+13,204
+5% +$201K 0.08% 419
2014
Q1 		$4.72M Buy
275,428
+6,428
+2% +$107K 0.09% 385
2013
Q4 		$3.95M Buy
269,000
+48,752
+22% +$671K 0.07% 430
2013
Q3 		$2.92M Buy
220,248
+124,984
+131% +$1.55M 0.06% 475
2013
Q2 		$1.02M Buy
+95,264
New +$1.07M 0.02% 640

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Kennedy Capital Management's PMD Position: Q4 2020 in Review

Kennedy Capital Management sold out of Psychemedics Corporation (PMD) in Q4 2020, closing a stake of 177,241 shares — an estimated $782K sold.

Kennedy Capital Management first reported a position in PMD in Q2 2013 and held it in 25 quarters. The position peaked at $4.86M in Q1 2015. 33 funds tracked by Wall St. Rank hold PMD as of Q4 2020.

  • Kennedy Capital Management reported no remaining Psychemedics Corporation position as of Q4 2020 after selling out during the quarter.
  • Kennedy Capital Management sold 177,241 Psychemedics Corporation shares in Q4 2020, an estimated $782K.
  • Kennedy Capital Management first reported a position in Psychemedics Corporation in Q2 2013 and held it in 25 quarters.
  • Kennedy Capital Management's Psychemedics Corporation position peaked at $4.86M in Q1 2015.
  • 33 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2020.

Based on Kennedy Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.